Search results for: 'partnering interact of amgen'
- Did you mean
- partnering interest of amgen
- Related search terms
- Partnering
- partnering agreementd with bigpharma
- partnering agreements with bigpharma
- Partnering Deals and Alliances with Big Pharma
- partnering interests of Amgen
-
Licensing Deals in Pharmaceuticals 2019-2024September 2024$3,995.00
Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Collaboration Deals in Biotechnology 2019-2024September 2024$3,995.00
Collaboration Deals in Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2024
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2024August 2024$3,995.00
Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2024
-
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024September 2024$3,995.00
Joint Venture Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Stem Cell Collaboration and Licensing Deals 2010-2024November 2024$3,995.00
Stem Cell Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2010 to 2024
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology DealsSeptember 2024$3,995.00
Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024September 2024$3,995.00
Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More -
Hospital Care Collaboration and Licensing Deals 2016-2024October 2024$3,995.00
Hospital Care Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More -
Metabolic Collaboration and Licensing Deals 2019-2024October 2024$3,995.00
Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More -
Genomic Collaboration and Licensing Deals 2018-2024November 2024$3,995.00
Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2024
Learn More